Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/mco2.12 http://scihub22266oqcxt.onion/10.1002/mco2.12 32838397!7436572!32838397     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32838397&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       MedComm+(2020) 2020 ; 1 (2): 157-164 Nephropedia Template TP {{tp|p=32838397|t=2020. Regulatory T cells: A potential weapon to combat COVID-19?|pdf=|usr=}}{{32838397}} gab.com Text Regulatory T cells: A potential weapon to combat COVID-19 JO: MedComm (2020) http://www.kidney.de/pget.php?&tw=1&pmid=32838397 #FOAvip Since the end of December 2019, a novel coronavirus SARS-CoV-2 began to spread, an infection disease termed COVID-19. The virus has spread throughout the world in a short period of time, resulting in a pandemic. The number of reported cases in global reached 5 695 596 including 352 460 deaths, as of May 27, 2020. Due to the lack of effective treatment options for COVID-19, various strategies are being tested. Recently, pathologic studies conducted by two teams in China revealed immunopathologic abnormalities in lung tissue. These results have implications for immunotherapy that could offer a novel therapy strategy for combating lethal viral pneumonia. This review discusses the clinical and pathological features of COVID-19, the roles of immune cells in pathological processes, and the possible avenues for induction of immunosuppressive T regulatory cells attenuating lung inflammation due to viral infection. It is our hope that these proposals may both be helpful in understanding the novel features of SARS-CoV-2 pneumonia as well as providing new immunological strategies for treating the severe sequelae of disease manifestations seen in people infected with SARS-CoV-2. Twit Text FOAVip Regulatory T cells: A potential weapon to combat COVID-19 ????MedComm (2020) http://www.kidney.de/pget.php?&tw=1&pmid=32838397 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32838397 #FOAvip English Wikipedia <ref>{{Cite pmid|32838397}}</ref> Regulatory T cells: A potential weapon to combat COVID-19? #MMPMID32838397 Liu Y; Qi G; Bellanti JA; Moser R; Ryffel B; Zheng SG MedComm (2020) 2020[Sep]; 1 (2): 157-164 PMID32838397show ga Since the end of December 2019, a novel coronavirus SARS-CoV-2 began to spread, an infection disease termed COVID-19. The virus has spread throughout the world in a short period of time, resulting in a pandemic. The number of reported cases in global reached 5 695 596 including 352 460 deaths, as of May 27, 2020. Due to the lack of effective treatment options for COVID-19, various strategies are being tested. Recently, pathologic studies conducted by two teams in China revealed immunopathologic abnormalities in lung tissue. These results have implications for immunotherapy that could offer a novel therapy strategy for combating lethal viral pneumonia. This review discusses the clinical and pathological features of COVID-19, the roles of immune cells in pathological processes, and the possible avenues for induction of immunosuppressive T regulatory cells attenuating lung inflammation due to viral infection. It is our hope that these proposals may both be helpful in understanding the novel features of SARS-CoV-2 pneumonia as well as providing new immunological strategies for treating the severe sequelae of disease manifestations seen in people infected with SARS-CoV-2. ?Regulatory T cells: A potential weapon to combat COVID-19?(epmc).pdf DeepDyve Pubget Overpricing